Since RANKL is upregulated by inflammatory factor tumor necrosis factor-α (TNF-α), which is upregulated in inflammation-associated diseases such as periodontitis, Kim et al. [30] injected diabetic and non-diabetic rats with infliximab, a TNF-α antagonist. This evidence concerns the gene TNF and periodontitis.